Product Information
Registration Status: ActiveSIN12288P
INFANRIX HEXA VACCINE is approved to be sold in Singapore with effective from 2003-07-05. It is marketed by GLAXOSMITHKLINE PTE LTD, with the registration number of SIN12288P.
This product contains Diphtheria Toxoid min 30 iu/0.5ml,Filamentous Haemagglutinin 25mcg/0.5ml,Hepatitis B Surface Antigen (Purified) 10mcg/0.5ml,Hib Purified Capsular Polysaccharide Bound To Tetanus Toxoid 10mcg/0.5ml,Pertactin (69 Kda Omp) 8mcg/0.5ml,Pertussis Toxoid 25mcg/0.5ml,Poliovirus Type 1 (Inactivated) 40 du/0.5ml,Poliovirus Type 2 (Inactivated) 8 du/0.5ml,Poliovirus Type 3 (Inactivated) 32 du/0.5ml, and Tetanus Toxoid min 40 iu/0.5ml in the form of INJECTION. It is approved for INTRAMUSCULAR use.
This product is manufactured by GLAXOSMITHKLINE BIOLOGICALS SA in BELGIUM,GlaxoSmithKline Biologicals in FRANCE, andGSK Biologicals in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) is a vaccine that contains inactivated acellular pertussis antigen that is isolated from Bordetella pertussis culture.
Active Ingredient/Synonyms
Bordetella pertussis filamentous hemagglutinin vaccine, inactivated | Filamentous haemagglutinin | Filamentous haemagglutinin adsorbed | Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Description
Clostridium tetani toxoid antigen (formaldehyde inactivated) is a vaccine for intramuscular injection. It is used for active immunization of children 7 years of age or older, and adults, for prevention of tetanus. The toxoid in the Clostridium tetani culture is grown and detoxified followed by purification via ammonium sulfate filtration and precipation.
Active Ingredient/Synonyms
Tetanus toxoid | Tetanus toxoid adsorbed | tetanus toxoid vaccine, inactivated | Clostridium tetani toxoid antigen (formaldehyde inactivated) |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.